Evidence map›Paper›PMID 41044834›Full record

ArticleAllergy, asthma & immunology research2025

Interleukin-17D Attenuates OVA-induced Airway Inflammation and Remodeling Partially via the CD93 Receptor.

Shuochuan Shi, Jintao Zhang, Yun Pan, Xiaofei Liu, Rong Zeng, Changjuan Xu, Ying Wang, Qian Qi, Zhi Guo, Chengfang Yao and 4 more

Abstract read
In one paragraph

Article in Allergy, asthma & immunology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shuochuan ShiDepartment of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Featured Laboratory of Respiratory Immunology and Regenerative Medicine in Universities of Shandong, Jinan Clinical Research Center for Respiratory Disease, Jinan, China.ORCID https://orcid.org/0009-0000-4648-4125
Jintao ZhangDepartment of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Featured Laboratory of Respiratory Immunology and Regenerative Medicine in Universities of Shandong, Jinan Clinical Research Center for Respiratory Disease, Jinan, China.ORCID https://orcid.org/0000-0002-1309-6836
Yun PanDepartment of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Featured Laboratory of Respiratory Immunology and Regenerative Medicine in Universities of Shandong, Jinan Clinical Research Center for Respiratory Disease, Jinan, China.ORCID https://orcid.org/0000-0002-5014-0322
Xiaofei LiuDepartment of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Featured Laboratory of Respiratory Immunology and Regenerative Medicine in Universities of Shandong, Jinan Clinical Research Center for Respiratory Disease, Jinan, China.ORCID https://orcid.org/0000-0002-7285-7578
Rong ZengDepartment of Respiratory, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, China.ORCID https://orcid.org/0000-0003-1320-8815
Changjuan XuDepartment of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Featured Laboratory of Respiratory Immunology and Regenerative Medicine in Universities of Shandong, Jinan Clinical Research Center for Respiratory Disease, Jinan, China.ORCID https://orcid.org/0000-0001-8414-2986
Ying WangDepartment of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Featured Laboratory of Respiratory Immunology and Regenerative Medicine in Universities of Shandong, Jinan Clinical Research Center for Respiratory Disease, Jinan, China.ORCID https://orcid.org/0009-0006-6200-4279
Qian QiDepartment of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Featured Laboratory of Respiratory Immunology and Regenerative Medicine in Universities of Shandong, Jinan Clinical Research Center for Respiratory Disease, Jinan, China.ORCID https://orcid.org/0000-0002-5813-3194
Zhi GuoDepartment of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Featured Laboratory of Respiratory Immunology and Regenerative Medicine in Universities of Shandong, Jinan Clinical Research Center for Respiratory Disease, Jinan, China.ORCID https://orcid.org/0009-0008-2146-5962
Chengfang YaoSchool of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.ORCID https://orcid.org/0000-0001-8860-2206
Ju LiuInstitute of Microvascular Medicine, Medical Research Center, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.ORCID https://orcid.org/0000-0001-9932-2613
Jianwen FeiPulmonary and Critical Care Medicine, Yantaishan Hospital, Yantai, China.ORCID https://orcid.org/0009-0000-2264-1536
Li LiDepartment of Respiratory Medicine, Haihe Hospital, Tianjin Medical University, Key Research Laboratory for infectious Disease Prevention for State Administration of Traditional Chinese Medicine, Tianjin Institution of Respiratory Diseases, Tianjin Key Laboratory of Lung Regenerative Medicine, Tianjin, China. lili0718@tju.edu.cn.ORCID https://orcid.org/0009-0001-5767-9662
Liang DongDepartment of Respiratory, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Respiratory Diseases, Featured Laboratory of Respiratory Immunology and Regenerative Medicine in Universities of Shandong, Jinan Clinical Research Center for Respiratory Disease, Jinan, China. dl5506@126.com.ORCID https://orcid.org/0000-0001-7707-9982

Funding

China International Medical Foundation Z-2014-08-2309-1China International Medical Foundation Z-2017-24-2301Jinan Clinical Medicine Research Program for Respiratory Disease 202132002Key Research and Development Program of Shandong Province 2021SFGC0504National Natural Science Foundation of China 82270032National Natural Science Foundation of China 82470028Natural Science Foundation of Shandong Province ZR2024MH153Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0529700Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0529704Shandong Provincial Natural Science Foundation ZR2021LSW015
6 · The paper itself

Abstract

purposeAirway inflammation and remodeling are pivotal in asthma pathogenesis. Interleukin-17D (IL-17D), a recently characterized cytokine within the IL-17 family, is found to be expressed at higher levels in lung tissue; however, its role in asthma remains unclear. This study aims to elucidate the function and mechanisms of IL-17D in asthma, providing new insights for therapeutic strategies.

methodsWe analyzed IL-17D messenger RNA expression levels using datasets from the Gene Expression Omnibus (GEO). Bronchoscopic biopsy tissues and serum samples from asthmatics, along with lung tissues from chronic asthmatic mice, were collected to validate IL-17D expression. Lentivirus-mediated IL-17D knockdown was performed in a chronic asthma mouse model induced by ovalbumin (OVA). Recombinant murine IL-17D protein was intranasally administered to further investigate its impact.

resultsGEO data and experimental findings revealed that IL-17D expression was reduced in the airway epithelia of asthmatics and chronic asthmatic mice.

conclusionsOur findings suggest that IL-17D could play a protective role in asthmatic airway inflammation and remodeling, partially through the CD93 receptors. These results highlight IL-17D as a potential therapeutic target for asthma management.

Indexed as

airway remodelingAsthmaepithelial-mesenchymal transitionIL-17Dinflammation

Identifiers

PMID41044834
PMCPMC12511793

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.